ID: ALA5191596

Max Phase: Preclinical

Molecular Formula: C32H50N6O10

Molecular Weight: 678.78

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCOC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OCc2ccccc2)[C@@H]1N=[N+]=[N-])C(N)=O

Standard InChI:  InChI=1S/C32H50N6O10/c1-4-5-6-7-8-12-17-45-25(40)16-15-23(29(33)42)36-30(43)20(2)35-31(44)21(3)47-28-26(37-38-34)32(48-24(18-39)27(28)41)46-19-22-13-10-9-11-14-22/h9-11,13-14,20-21,23-24,26-28,32,39,41H,4-8,12,15-19H2,1-3H3,(H2,33,42)(H,35,44)(H,36,43)/t20-,21+,23+,24+,26+,27+,28+,32-/m0/s1

Standard InChI Key:  YDYJRWYKYGMKPI-NPYKDBGNSA-N

Associated Targets(Human)

Nucleotide-binding oligomerization domain-containing protein 2 1613 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Peritoneal macrophage 1554 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 678.78Molecular Weight (Monoisotopic): 678.3588AlogP: 1.89#Rotatable Bonds: 22
Polar Surface Area: 244.50Molecular Species: ACIDHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.30CX Basic pKa: CX LogP: 1.96CX LogD: 1.85
Aromatic Rings: 1Heavy Atoms: 48QED Weighted: 0.04Np Likeness Score: 0.71

References

1. Reddy PRS, Sambyal S, Mhamane TB, Sravanthi V, Shafi S, Khan IA, Sampath Kumar HM..  (2022)  Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants.,  66  [PMID:35569249] [10.1016/j.bmc.2022.116781]

Source